Home / Community / News

News

09/22/2016 - 11:33am

Since DM1-related loss of muscle mass confounds a common biomarker of kidney dysfunction, creatinine levels, serum cystatin C provides a superior measure of renal dysfunction for both patient management and clinical trials.

 

09/22/2016 - 11:24am

A recent study corroborated increased susceptibility to cancer in DM1, for women in particular, and linked the elevated risk to depressed levels of a tumor suppressor microRNA (miRNA). 

08/19/2016 - 3:15pm

Acclaimed musician Eric Hutchinson is using his new album to support Care and a Cure. Read his inspiring family story.

08/10/2016 - 12:42pm

AMO Pharma Limited (AMO Pharma) today announced initiation of a phase 2 clinical study in the U.K. for AMO-02 (tideglusib).

08/09/2016 - 4:41pm

Dr. Gallais and his team are conducting a longitudinal study of cognition and central nervous system involvement in DM1. Read an interview with Dr. Gallais on this work here.Highlights from IDMC-10

Partners

© Myotonic Dystrophy Foundation. All rights reserved.